- Home
- BCYC vs TCMD Comparison
BCYC vs TCMD Comparison
Compare BCYC & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCYC | TCMD |
|---|---|---|
| Founded | 2009 | 1995 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 360.7M | 300.1M |
| IPO Year | 2019 | 2016 |
Fundamental Metrics
Financial Performance| Metric | BCYC | TCMD |
|---|---|---|
| Price | $4.82 | $26.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $17.56 | ★ $36.00 |
| AVG Volume (30 Days) | 333.2K | ★ 408.9K |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.91 | 17.14 |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.60 |
| Revenue Next Year | N/A | $9.14 |
| P/E Ratio | ★ N/A | $33.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.00 | $8.61 |
| 52 Week High | $10.13 | $37.77 |
Technical Indicators
Market Signals| Indicator | BCYC | TCMD |
|---|---|---|
| Relative Strength Index (RSI) | 31.51 | 39.57 |
| Support Level | N/A | $26.47 |
| Resistance Level | $7.71 | $30.74 |
| Average True Range (ATR) | 0.27 | 1.16 |
| MACD | -0.03 | -0.27 |
| Stochastic Oscillator | 4.00 | 13.85 |
Price Performance
Historical ComparisonAbout BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.